New York, Dec 7 (IANS) In a bid to find cure for blindness on Earth, a US-based pharma start-up aims to leverage microgravity on Low Earth Orbit (LEO) to manufacture artificial retina in space. The company LambdaVision will use the microgravity environment on the International Space Station (ISS) to develop a synthetic retinal implant that will restore sight to humans with degenerative eye diseases. “LambdaVision is designing and developing an innovative, protein-based artificial retina that utilises a light-activated protein, bacteriorhodopsin, to restore functional sight to those who would otherwise be blind due to retinal degenerative diseases, including age-related macular degeneration
Hence then, the article about us pharma start up to manufacture artificial retina in space was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( US pharma start-up to manufacture artificial retina in space )